Y. Tsubouchi et al., Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis, BIOC BIOP R, 270(2), 2000, pp. 400-405
Citations number
41
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Peroxisome proliferator-activated receptors (PPARs), members of the nuclear
hormone receptors superfamily, have an important regulatory role in adipog
enesis and inflammation. PPAR-gamma Ligands induce terminal differentiation
and growth inhibition of human breast cancer cells and prostatic cancer ce
lls. In this study, we demonstrated that PPAR-gamma, but not PPAR-alpha, wa
s expressed in human lung cancer cell lines by reverse transcription-polyme
rase chain reaction (RT-PCR) and Western blot analysis. We also found that
the synthetic PPAR-gamma agonist thiazolidinedione compounds (troglitazone)
and the endogenous PPAR-gamma hgand, 15-deoxy-Delta(12,14)-prostaglandin J
(2) (15d-PGJ(2)), inhibited the growth of human lung cancer cells through t
he induction of apoptosis. However, PPAR-alpha agonist (bezafibrate) and ot
her prostanoids (PGE(2), PGF(2 alpha)) did not induce apoptosis. These find
ings suggest that PPAR-gamma may play an important role in the pathogenesis
of lung cancer and that PPAR-gamma agonist may be useful therapeutic agent
s in the treatment of human lung cancer. (C) 2000 Academic Press.